Table 4 |
||||
|
Correlations between anthropometric data, clinical findings and bone density measurements in patients with psoriatic arthritis |
||||
|
Vertebral |
Femur |
TLM |
TBF |
|
|
BMD |
BMD |
|||
|
|
||||
|
Age r* |
-0.05 |
-0.09 |
0.11 |
0.02 |
|
(P) |
(0.76) |
(0.53) |
(0.45) |
(0.86) |
|
Weight r* |
0.27 |
0.13 |
0.63 |
0.59 |
|
(P) |
(0.78) |
(0.39) |
(<0.001) |
(<0.001) |
|
BMI r* |
0.16 |
0.20 |
0.35 |
0.63 |
|
(P) |
(0.30) |
(0.17) |
(0.02) |
(<0.001) |
|
Duration of Ps r* |
0.23 |
0.02 |
0.13 |
-0.10 |
|
(P) |
(0.13) |
(0.88) |
(0.37) |
(0.52) |
|
Duration of PsA r† |
0.14 |
0.09 |
0.14 |
0.15 |
|
(P) |
(0.34) |
(0.55) |
(0.35) |
(0.34) |
|
Duration of menopause r† |
-0.29 |
-0.14 |
0.07 |
-0.04 |
|
(P) |
(0.04) |
(0.37) |
(0.64) |
(0.79) |
|
HAQ r† |
0.04 |
0.01 |
-0.27 |
-0.02 |
|
(P) |
(0.8) |
(0.93) |
(0.08) |
(0.91) |
|
PASI r† |
0.08 |
-0.13 |
0.13 |
-0.15 |
|
(P) |
(0.6) |
(0.39) |
(0.38) |
(0.31) |
|
DAS 28 r* |
-0.13 |
-0.19 |
-0.12 |
0.12 |
|
(P) |
(0.39) |
(0.2) |
(0.41) |
(0.43) |
|
PsARC for swollen joints r† |
0.13 |
-0.16 |
-0.01 |
0.02 |
|
(P) |
(0.41) |
(0.29) |
(0.94) |
(0.88) |
|
PsARC for painful joints r† |
-0.13 |
-0.03 |
0.07 |
0.01 |
|
(P) |
(0.38) |
(0.86) |
(0.63) |
(0.93) |
|
PsARC (VAS) - patient r† |
0.05 |
-0.01 |
-0.15 |
0.08 |
|
(P) |
(0.74) |
(0.91) |
(0.32) |
(0.57) |
|
PsARC (VAS) - physician r† |
0.01 |
0.01 |
-0.62 |
0.05 |
|
(P) |
(0.93) |
(0.94) |
(0.69) |
(0.75) |
|
TLM r* |
0.19 |
0.15 |
1 |
-0.22 |
|
(P) |
(0.2) |
(0.33) |
(0.15) |
|
|
TBF r* |
0.11 |
-0.006 |
-0.22 |
1 |
|
(P) |
(0.48) |
(0.97) |
(0.15) |
|
|
|
||||
|
r*, Pearson's correlation; r†, Spearman's correlation |
||||
|
Pedreira et al. Arthritis Research & Therapy 2011 13:R16 doi:10.1186/ar3240 |
||||
